Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment - PubMed (original) (raw)

Comparative Study

Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment

F Noble et al. Br J Pharmacol. 1996 Jan.

Abstract

1. Morphine produces a plethora of pharmacological effects and its chronic administration induces several side-effects. The cellular mechanisms by which opiates induce these side-effects are not fully understood. Several studies suggest that regulation of adenylyl cyclase activity by opioids and other transmitters plays an important role in the control of neural function. 2. The aim of this study was to evaluate desensitization of mu- and delta- opioid receptors, defined as a reduced ability of opioid agonists to inhibit adenylyl cyclase activity, in four different brain structures known to be involved in opiate drug actions: caudate putamen, nucleus accumbens, thalamus and periaqueductal gray (PAG). Opiate regulation of adenylyl cyclase in these regions has been studied in control and morphine-dependent rats. 3. The chronic morphine treatment used in the present study (subcutaneous administration of 15.4 mg morphine/rat/day for 6 days via osmotic pump) induced significant physical dependence as indicated by naloxone-precipitated withdrawal symptoms. 4. Basal adenylyl cyclase in the four brain regions was not modified by this chronic morphine treatment. In the PAG and the thalamus, a desensitization of mu- and delta-opioid receptors was observed, characterized by a reduced ability of Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol (DAMGO; mu), Tyr-D-Pen-Gly-Phe-D-Pen (DPDPE; delta) and [D-Ala2]-deltorphin-II (DT-II; delta) to inhibit adenylyl cyclase, activity following chronic morphine treatment. 5. The opioid receptor desensitization in PAG and thalamus appeared to be heterologous since the metabotropic glutamate receptor agonists, L-AP4 and glutamate, and the 5-hydroxytryptamine (5-HT)1A receptor agonist, R(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT), also showed reduced inhibition of adenylyl cyclase activity following chronic morphine treatment. 6. In the nucleus accumbens and the caudate putamen, desensitization of delta-opioid receptor-mediated inhibition without modification of mu-opioid receptor-mediated inhibition was observed. An indirect mechanism probably involving dopaminergic systems is proposed to explain the desensitization of delta-mediated responses and the lack of mu-opioid receptor desensitization after chronic morphine treatment in caudate putamen and nucleus accumbens. 7. These results suggest that adaptive responses occurring during chronic morphine administration are not identical in all opiate-sensitive neural populations.

PubMed Disclaimer

Cited by

Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA, Selley DE, Sim-Selley LJ, Welch SP. Smith PA, et al. Eur J Pharmacol. 2007 Oct 1;571(2-3):129-37. doi: 10.1016/j.ejphar.2007.06.001. Epub 2007 Jun 12. Eur J Pharmacol. 2007. PMID: 17603035 Free PMC article.
Disulfiram Abrogates Morphine Tolerance-A Possible Role of µ-Opioid Receptor-Related G-Protein Activation in the Striatum.
de Corde-Skurska A, Krzascik P, Lesniak A, Sacharczuk M, Nagraba L, Bujalska-Zadrozny M. de Corde-Skurska A, et al. Int J Mol Sci. 2021 Apr 14;22(8):4057. doi: 10.3390/ijms22084057. Int J Mol Sci. 2021. PMID: 33919998 Free PMC article.
Opioid receptor desensitization: mechanisms and its link to tolerance.
Allouche S, Noble F, Marie N. Allouche S, et al. Front Pharmacol. 2014 Dec 18;5:280. doi: 10.3389/fphar.2014.00280. eCollection 2014. Front Pharmacol. 2014. PMID: 25566076 Free PMC article. Review.
Impact of opium dependency on clinical and neuropsychological indices of multiple sclerosis patients.
Ayoobi F, Bidaki R, Shamsizadeh A, Moghadam-Ahmadi A, Amiri H. Ayoobi F, et al. Neurol Sci. 2019 Dec;40(12):2501-2507. doi: 10.1007/s10072-019-03971-8. Epub 2019 Jul 1. Neurol Sci. 2019. PMID: 31264108
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK, Paris JJ, Lichtman AH, Hauser KF, Sim-Selley LJ, Selley DE, Knapp PE. Hahn YK, et al. Neurobiol Dis. 2016 Aug;92(Pt B):124-36. doi: 10.1016/j.nbd.2016.01.014. Epub 2016 Feb 1. Neurobiol Dis. 2016. PMID: 26845176 Free PMC article.

References

1. Eur J Pharmacol. 1994 Jul 15;268(2):215-21 - PubMed
1. J Pharmacol Exp Ther. 1992 May;261(2):669-77 - PubMed
1. Neuropharmacology. 1994 Mar-Apr;33(3-4):261-73 - PubMed
1. Neurosci Biobehav Rev. 1994 Fall;18(3):373-83 - PubMed
1. Trends Neurosci. 1994 Sep;17(9):379-89 - PubMed

Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment - PubMed (original) (raw)